Table 1 Clinical, demographic, serological, and therapeutic characteristics of patients with RA and HC
Patients with RA (n = 20) | HC (n = 20) | |
|---|---|---|
Demographic parameters | ||
Female/male | 19/1 | 20/0 |
Age, years (median (IQR)) | 58.5 (50–67) | 58 (50–65) |
Disease duration, years (mean ± SD), | 5.3 ± 5.6 | |
Disease activity | ||
DAS28 (mean ± SD) | 4.1 ± 1.7 | |
TJ, n (mean ± SD) | 6.16 ± 5.9 | |
SJ, n (mean ± SD) | 2.79 ± 2.7 | |
CDAI (mean ± SD) | 18.8 ± 10.7 | |
HAQ (mean ± SD) | 1.15 ± 0.8 | |
Laboratory parameters | N (%) | |
RF+ | 15 (75) | |
ACPA+ | 15(75) | |
ESR, mm/h (mean ± SD) | 16.5 ± 10.3 | |
CRP, mg/dl (mean ± SD) | 0.7 ± 0.73 | |
Therapy | ||
Concurrent csDMARDs (n (%)) | 20 (100) | |
ETA (n (%)) | 20 (100) | |